Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Rocket Pharmaceuticals Inc RCKT

Healthcare Biotechnology
Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage biotechnology company. The Company is advancing a sustainable pipeline of investigational genetic therapies designed to correct the root cause of complex and rare disorders. Its lentiviral (LV) vector-based gene therapies target hematologic diseases and consist of late-stage programs for Fanconi Anemia, a difficult to treat genetic... see more

Recent & Breaking News (NDAQ:RCKT)

Rocket Pharmaceuticals to Join Russell 3000® and 2000® Indexes

Business Wire June 22, 2018

Rocket Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference

Business Wire May 30, 2018

Rocket Pharmaceuticals Presents Updated Data from Phase 1/2 Gene Therapy Trial of RP-L102 in Patients with Fanconi Anemia at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Business Wire May 18, 2018

Rocket Pharmaceuticals Announces Strategic Research Collaboration

Business Wire May 17, 2018

Rocket Pharmaceuticals Appoints Gayatri R. Rao, M.D., J.D., Former U.S. Food and Drug Administration Director of the Office of Orphan Products Development, as Vice President, Regulatory Policy and Patient Advocacy

Business Wire May 15, 2018

Rocket Pharmaceuticals Reports First Quarter 2018 Financial Results and Operational Highlights

Business Wire May 11, 2018

Rocket Pharmaceuticals to Present at Upcoming Investor Conferences

Business Wire May 8, 2018

Rocket Pharmaceuticals Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Business Wire April 30, 2018

Rocket Pharmaceuticals Reports Full Year 2017 Financial Results and Operational Highlights

Business Wire March 6, 2018

Rocket Pharmaceuticals to Present at the Cowen & Company 38th Annual Health Care Conference

Business Wire March 5, 2018

Rocket Pharmaceuticals Announces Participation in a Fireside Chat at the Leerink Partners 7th Annual Global Healthcare Conference

Business Wire February 7, 2018

Rocket Pharmaceuticals Prices Public Offering of Common Stock

Business Wire January 24, 2018

9 Stocks Moving In Tuesday's After-Hours Session

Benzinga.com  January 23, 2018

Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock

Business Wire January 23, 2018

Rocket Pharmaceuticals and Inotek Pharmaceuticals Complete Merger Transaction

Business Wire January 4, 2018